Ekström Magnus, Vergo Maxwell T, Ahmadi Zainab, Currow David C
Division of Respiratory Medicine and Allergology, Department of Clinical Sciences, Lund University, Lund, Sweden; Discipline, Palliative and Supportive Services, Flinders University, Adelaide, South Australia.
Palliative Medicine and Hospice Care, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, USA.
J Pain Symptom Manage. 2016 Aug;52(2):221-7. doi: 10.1016/j.jpainsymman.2016.02.015. Epub 2016 May 21.
Advanced, life-limiting illnesses are likely to have a predictable functional decline through a terminal phase to death, but some patients may also die suddenly. To date, empirical evidence characterizing "sudden death" in hospice/palliative care is lacking.
The aim of this study was to determine prevalence and clinicodemographic predictors of sudden death in hospice/palliative care.
This is a longitudinal consecutive cohort study of prospectively collected national data in 104 specialist palliative care services from the Australian Palliative Care Outcomes Collaboration. Patients who died between July 1, 2013, and June 30, 2014, with one or more measurement of Australian-modified Karnofsky Performance Status (AKPS) in the last 30 days of life were included. "Sudden death" was defined as a lowest AKPS score of 50 or more in the last seven days of life and excluded anyone with "terminal phase" as their last phase before death. Predictors were defined using logistic regression.
In total, 13,966 patients were included, mean age 73.6 (SD 13.6) years, 46% women, and 77% had cancer. During the seven days before death, there were 20,992 AKPS measurements; median 1 (interquartile range 1-2) per patient. Four percent of deaths (one of 25) were sudden, predicted independently by having lung cancer (odds ratio [OR] 2.64), cardiovascular disease (OR 1.94), other cancers (OR 1.63), being male (OR 1.23), younger, worse fatigue, and worse breathlessness. Sudden death was associated with higher rates of death at home (OR 3.2; 95% CI 2.9 to 3.6).
This study quantifies rates of sudden death in hospice/palliative care and has implications for conversations about prognosis between clinicians, patients, and their families.
晚期绝症患者在临终阶段可能会出现可预测的功能衰退直至死亡,但有些患者也可能突然离世。迄今为止,缺乏关于临终关怀/姑息治疗中“猝死”特征的实证证据。
本研究旨在确定临终关怀/姑息治疗中猝死的患病率及临床人口统计学预测因素。
这是一项纵向连续队列研究,前瞻性收集了澳大利亚姑息治疗结果协作组织104家专科姑息治疗服务机构的全国数据。纳入2013年7月1日至2014年6月30日期间死亡、且在生命的最后30天内有一次或多次澳大利亚改良卡氏功能状态评分(AKPS)测量值的患者。“猝死”定义为生命最后七天内AKPS最低评分为50分或更高,且排除任何在死亡前最后阶段为“终末期”的患者。使用逻辑回归定义预测因素。
共纳入13966例患者,平均年龄73.6(标准差13.6)岁,46%为女性,77%患有癌症。在死亡前七天内,共有20992次AKPS测量值;每位患者的中位数为1(四分位间距1 - 2)。4%的死亡(25例中的1例)为猝死,独立预测因素包括患有肺癌(比值比[OR] 2.64)、心血管疾病(OR 1.94)、其他癌症(OR 1.63)、男性(OR 1.23)、年龄较小、疲劳更严重和呼吸急促更严重。猝死与在家中死亡的比例较高相关(OR 3.2;95%置信区间2.9至3.6)。
本研究对临终关怀/姑息治疗中的猝死发生率进行了量化,对临床医生、患者及其家属之间关于预后的沟通具有启示意义。